Rituximab Offers No Extra Benefit to Induction Chemo in ALL Rituximab Offers No Extra Benefit to Induction Chemo in ALL

Patients with B-precursor acute lymphoblastic lymphoma may not benefit from adding rituximab to standard induction chemotherapy, suggests UK trial data that also identified novel genetic risk factors.Medscape News UK
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news